REVBW · Revelation Biosciences, Inc.
$0.01
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not anticipate that our current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that our unaudited financial statements for June 30, 2026 were issued, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$2.16M
Shares
569,059
Volume · Oct 26
866
Avg daily vol (3M)
24.11K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.01
Open$0.01
Day$0.01–0.01
Available close range$0.00–0.01
Avg vol 30d23K
DataJul 2026–Oct 2026
Filing10-Q · Aug 6
The closing range uses available history since Jul 23, 2026; less than a full year is stored.
Up next
filed Aug 6, 2026
Technicals
trend & momentum for long-term holders illustrative — not investment adviceMarket signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Distributing
3 of 25 funds reported for Sep 30 · net -49 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Flat
No short-interest data
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
25 holders — near 3-yr high, broad support
Price context
position in its available closing range
Range low $0
Now $0 · 20%
Range high $0
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
REVBW
this stock
Revelation Biosciences, Inc.
|
$2.16M | — | — | — | — |
|
VRTX
Vertex Pharmaceuticals Inc
|
$130.00B | +14.1% | +46.2% | 29.9 | 1.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.88B | +4.6% | +20.8% | 19.9 | 2.1% |
|
MRNA
Moderna, Inc.
|
$79.89B | +574.3% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$66.42B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
24
- % held
- 246.8%
- Reported
- 3 of 25
- Top holder
- Linden Advisors LP
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| REVBW | -12.5% | -16.4% | — | -23.3% | — |
| SPY | -0.1% | 0.0% | +5.8% | +0.4% | +12.2% |
| vs SPY | -12.4% | -16.4% | — | -23.7% | — |